Martínez, C., Riveiro, B., Muñoz, G., Londoño, M., Roget, M., et al., Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy, Gastroenterol. Hepatol., 2023, vol. 46, no. 8, pp. 594–602. https://doi.org/10.1016/j.gastrohep.2022.12.004

Google Scholar 

Farooq, A., Butt, B., Butt, N., ArzuJadoon, D., and Ijaz, Comparison of hemoglobin levels between hepatitis positive and negative patients in dialysis unit of a tertiary care hospital, NeuroQuantology, 2023, vol. 21, no. 2, pp. 149–156. https://doi.org/10.48047/NQ.2023.21.2.NQ23016

WHO, Global Hepatitis Report, 2023, https://www. who.int/news-room/events/de tail/2023/04/25/default-calendar/who-at-the-global-hepatitis-summit-2023.

Heo, M., Norton, B., Pericot, V., Mehta, S., Tsui, J., et al., Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: the HERO study, J. Hepatol., 2024, vol. 80, no. 5, pp. 702–713. https://doi.org/10.1016/j.jhep.2023.12.020

Indolfi, G., Gonzalez, R., Jonas, M., Sayed, M., Fischler, B., et al., ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings, J. Pediatr. Gastroenterol. Nutr., 2024, vol. 78, no. 4, pp. 957–972. https://doi.org/10.1002/jpn3.12160

Article  CAS  PubMed  Google Scholar 

Greeviroj, P., Lertussavavivat, T., Thongsricome, T., Takkavatakarn, K., Phannajit, J., et al., The world prevalence, associated risk factors and mortality of hepatitis C virus infection in hemodialysis patients: a meta-analysis, J. Nephrol., 2022, vol. 35, no. 9, pp. 2269–2282.

PubMed  PubMed Central  Google Scholar 

Bender, D., Koulouri, A., Wen, X., Glitscher, M., Schollmeier, et al., Guanylate-binding protein 1 acts as a pro-viral factor for the life cycle of hepatitis C virus, PLoS Pathog., 2024, vol. 20, no. 2, p. e1011976. https://doi.org/10.1371/journal.ppat.1011976

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frericks, N., Brown, R., Reinecke, B., Herrmann, M., Brüggemann, Y., et al., Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes, J. Virol., 2024, vol. 98, no, 3, p. 0192123.

Google Scholar 

Pirakitikulr, N., Kohlway, A., Lindenbach, B., and Pyle, A., The coding region of the HCV genome contains a network of regulatory RNA structures, Mol. Cell, 2016, vol. 62, no. 1, pp. 111–120. https://doi.org/10.1016/j.molcel.2016.01.024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian, X. and Qi, Z., Entry inhibitors of hepatitis C virus, in Virus Entry Inhibitors, Cham: Springer, 2022, pp. 207–222. https://doi.org/10.1007/978-981-16-8702-0_13

Martino, S.D., Petri, G.L., and De Rosa, M., Hepatitis C: the story of a long journey through first, second, and third generation NS3/4A peptidomim etic inhibitors. What did we learn?, J. Med. Chem., 2024, vol. 67, no. 2, pp. 885–921.

CAS  PubMed  Google Scholar 

Gorgzadeh, A., Nazari, A., Ismaeel, A.A.E., Safarzadeh, D., Hassan, J.A., et al., A state-of-the-art review of the recent advances in exosome isolation and detection methods in viral infection, Virol. J., 2024, vol. 21, no. 1, p. 34.

PubMed  PubMed Central  Google Scholar 

Cheng, P.N., Sun, H.Y., Feng, I.C., Chiu, Y.C., Wang, S.T., et al., Interdependence of glycemic and lipid modulation in cured chronic hepatitis C patients by direct-acting antiviral agents, J. Microbiol. Immunol. Infect., 2023, vol. 56, no. 1, pp. 20–30. https://doi.org/10.1016/j.jmii.2022.06.004

Article  CAS  PubMed  Google Scholar 

Poddar, S., Roy, R., and Kar, P., The conformational dynamics of Hepatitis C Virus E2 glycoprotein with the increasing number of N-glycosylation unraveled by molecular dynamics simulations, J. Biomol. Struct. Dyn., 2024, pp. 1–16. https://doi.org/10.1080/07391102.2024.2319679

Aizawa, Y., Seki, N., Nagano, T., and Abe, H., Chronic hepatitis C virus infection and lipoprotein metabolism, World J. Gastroenterol., 2015, vol. 21, no. 36, p. 10299. https://doi.org/10.3748/wjg.v21.i36.10299

Article  CAS  PubMed  PubMed Central  Google Scholar 

Negro, F., Abnormalities of lipid metabolism in hepatitis C virus infection, Gut, 2010, vol. 59, no. 9, pp. 1279–1287. https://doi.org/10.1136/gut.2009.192732

Article  CAS  PubMed  Google Scholar 

Ferreira, J., Bicho, M., and Serejo, F., Effects of HCV clearance with direct-acting antivirals (DAAs) on liver stiffness, liver fibrosis stage and metabolic/cellular parameters, Viruses, 2024, vol. 16, no. 3, p. 371. https://doi.org/10.3390/v16030371

Herker, E., Lipid droplets in virus replication, FEBS J., 2024, vol. 598, no. 10, pp. 1299–1300. https://doi.org/10.1002/1873-3468.14819

Article  CAS  Google Scholar 

Lee, J. and Ou, J., HCV-induced autophagy and innate immunity, Front. Immunol., 2024, vol. 15, p. 1305157. https://doi.org/10.3389/fimmu.2024.1305157

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chuang, Y. and James, J., Regulation of hepatitis B virus replication by autophagic membranes, Autophagy, 2023, vol. 19, no. 4, pp. 1357–1358. https://doi.org/10.1080/15548627.2022.2117974

Article  CAS  PubMed  Google Scholar 

Bunz, M., Eisele, M., Hu, D., Ritter, M., Kammerloher, J., et al., CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells, Front. Cell. Infect. Microbiol., 2024, vol. 14, p. 1338606. https://doi.org/10.3389/fcimb.2024.1338606

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowicki, M.J., Balistreri, W.F., and Whitman, W., The hepatitis C virus: identification, epidemiology and clinical controversies, J. Pediatr. Gastroenterol. Nutr., 1995, vol. 20, no. 3, pp. 248–274.

CAS  PubMed  Google Scholar 

Dilnoza, Q. and Dilnoza, Z., Hepatitis C—Symptoms, treatment, in Proceedings of International Conference on Educational Discoveries and Humanities, 2024, vol. 3, no. 1, pp. 196–198.

Yang, D., Lu, J., Zhang, Z., Sun, C., Xu, Z., et al., Diagnosis, treatment, and associated factors among patients with HCV Infection—iangsu Province, China, 2004–2020, China CDC Weakly, 2024, vol. 6, no. 1, pp. 1–5.

Google Scholar 

Campos, M., Panduro, A., Gonzalez, A., Laguna, M., and Roman, S., Hepatitis C virus-infected patients’ carriers of the TT (C*52T, rs14158) genotype of the LDL receptor and Apo3 present severe liver damage in West Mexico, Ann. Hepatol., 2024, vol. 29, no. 2, p. 101457. https://doi.org/10.10161/j.aohep.2024.101457

Article  Google Scholar 

Abdelhai, S., Hussien, H., Ibraheem, H., and Badawy, A., Evaluation of lipid profile in patients with hepatitis C virus related liver cirrhosis, Afro-Egypt. J. Infect. Endem. Dis., 2023, vol. 13, no. 1, pp. 35–42. https://doi.org/10.21608/AEJI.2022.171614.1265

Article  Google Scholar 

Wang, C., Huang, C., Yeh, M., Chen, S., Hung, C., et al., Hepatitis C virus infection associated with coronary and thoracic aortic atherosclerosis, Am. J. Med. Sci., 2024, vol. 368, no. 3, pp. 203–213. https://doi.org/10.1016/j.amjms.2024.02.004

Article  PubMed  Google Scholar 

Ceja, G., Aranda, A., Amador, M., Aparicio, O., Tapia, E., et al., The development of dyslipidemia in chronic kidney disease and associated cardiovascular damage, and the protective effects of curcuminoids, Foods, 2023, vol. 12, no. 5, p. 921. https://doi.org/10.3390/foods12050921

Liu, S., Qiu, C., Li, W., Li, X., Liu, F., Hu, G., et al., Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in type 2 diabetes mellitus patients with chronic kidney disease, Sci. Rep., 2024, vol. 14, no. 1, p. 8002. https://doi.org/10.1048/s41598-024-58678-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elkhawaga, A., El-Mokhtar, M., Mahmoud, A., Ali, W., Mohamed, D., et al., First report on abnormal renal function in acute hepatitis E genotype 1 infection, Pathogens, 2023, vol. 12, no. 5, p. 687. https://doi.org/10.3390/pathogens12050687

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su, P., Chang, T., Tung, S., Wei, K., Shen, C., et al., Changes in renal function in patients with chronic hepatitis C treated with sofosbuvir-velpatasvir, Adv. Dig. Med., 2023, vol. 3, no. 10, pp. 150–158. https://doi.org/10.1002/aid2.13336

Article  Google Scholar 

Souza, G., Silva, L., Vieira, D., Rocha, G., Lima, A., et al., High-density lipoprotein cholesterol and systemic arterial hypertension are associated with hepatic necroinflammatory activity in patients with chronic hepatitis C, Arq. Gastroenterol., 2023, vol. 60, no. 3, pp. 287–299. https://doi.org/10.1590/S0004-2803.230302023-03

Rao, A., Avila, C., Agrawal, V., and Kaushal, A., Lipoprotein glomerulopathy with membranoproliferative pattern in a patient with cholestatic liver disease-lesson for the clinical nephrologist, J. Nephrol., 2023, vol. 36, no. 8, pp. 2391–2394. https://doi.org/10.1007/s40620-023-01653-5

Article  Google Scholar 

Baek, J., He, C., Afshinnia, F., Michailidis, G., and Pennathur, S., Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease, Nat. Rev. Nephrol., 2022, vol. 1, no. 18, pp. 38–55. https://doi.org/10.1038/s41581-021-00488-2

Article  CAS  Google Scholar 

Theofilis, P., Vordoni, A., Koukoulaki, M., Vlachopanos, G., and Kalaitzidis, R.G., Dyslipidemia in chronic kidney disease: contemporary concepts and future therapeutic perspectives, Am. J. Nephrol., 2021, vol. 9, no. 52, pp. 693–701. https://doi.org/10.1159/000518456

Article  CAS  Google Scholar 

Jones, S., Close, C., Mattock, M., Jarrett, R., Keen, H., et al., Plasma lipid and coagulation factor concentrations in insulin-dependent diabetic patients with microalbuminuria, BMJ, 1998, vol. 298, pp. 487–490. https://doi.org/10.1136/bmj.298.6672.487

Trevisan, R., Dodesini, A., and Lepore, G., Lipids and renal disease, J. Am. Soc. Nephrol., 2006, vol. 17, pp. 145–147. https://doi.org/10.1681/ASN.2005121320

Article  CAS  Google Scholar 

Balode, A. and Khan, Z., Serum lipid profile in chronic kidney disease patients on haemodialysis, Indian J. Ap-pl. Res., 2011, vol. 3, no. 8, pp. 20–22.

Google Scholar 

Syed, G.H., Amako, Y., and Siddiqui, A., Hepatitis C virus hijacks host lipid metabolism, Trends Endocrinol. Metab., 2010, vol. 21, no. 1, pp. 33–40.

CAS  PubMed